GENDER REASSIGNMENT THERAPY

GENDER REASSIGNMENT THERAPY was reported 11 times

GENDER REASSIGNMENT THERAPY is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Hydrolytic Lysosomal Glycogen-specific Enzyme [EPC] 1 0.0003
1 GLP-2 Analog [EPC] 1 0.0001
2 Non-narcotic Antitussive [EPC] 1 0.0001
3 Hemoglobin S Polymerization Inhibitor [EPC] 1 0.0000
4 Progesterone [EPC] 1 0.0000
5 Cholinergic Muscarinic Antagonist [EPC] 1 0.0000
6 Nitroimidazole Antimicrobial [EPC] 1 0.0000
7 Catecholamine [EPC] 1 0.0000
8 Histamine-2 Receptor Antagonist [EPC] 1 0.0000
9 Serotonin-3 Receptor Antagonist [EPC] 1 0.0000
10 Opioid Agonist [EPC] 2 0.0000
11 Retinoid [EPC] 1 0.0000
12 Factor Xa Inhibitor [EPC] 1 0.0000
13 Vitamin D [EPC] 1 0.0000
14 Vitamin B12 [EPC] 1 0.0000
15 Dihydropyridine Calcium Channel Blocker [EPC] 1 0.0000
16 Vitamin C [EPC] 1 0.0000
17 Corticosteroid [EPC] 1 0.0000